Literature DB >> 33734873

Pulmonary Infections and Surgical Complications in a Young Girl with Signal Transducer and Activator of Transcription 3 Loss-of-Function Mutation Hyperimmunoglobulin E Syndrome: A Case Report.

Crhistian Toribio-Dionicio1, Dania Cubas-Guzmán1, Pedro Guerra-Canchari2, Vanuza García-Sánchez3, Wilmer Córdova-Calderón4.   

Abstract

Introduction: Hyperimmunoglobulin E syndromes (HIESs) are characterized by a high serum immunoglobulin E (IgE) level, eczematoid rashes, recurrent staphylococcal skin abscesses, and recurrent pneumonia and pneumatocele formation. Autosomal dominant HIES is the most common form of HIES and mainly occurs due to loss-of-function mutations in the Signal Transducer and Activator of Transcription 3 (STAT3) gene (STAT3 LOF). Case Presentation: We report the case of an 11-year-old Peruvian girl diagnosed with STAT3 LOF caused by p.R382W mutation. She presented with recurrent staphylococcal pneumonia and empyema caused by the rarely reported Achromobacter xylosoxidans, which led to severe destruction of the lung parenchyma, multiple lung surgeries, and the development of bronchopleural fistulas. A laparotomy was also performed, which showed evidence of sigmoid colon perforation. The patient received immunoglobulin replacement therapy (IRT) and antibiotic prophylaxis, and the frequency of her infections has decreased over the past 3 years.
Conclusion: This is the first case of STAT3 LOF diagnosed by genomic sequencing in Peru. Patients with this mutation have recurrent pulmonary infections, and require multiple surgical procedures with frequent complications. A. xylosoxidans infection could be related to the prolonged stay in intensive care leading to high mortality; therefore, additional care must be taken when treating patients with this infection. In addition, colonic perforation is a rare complication in STAT3 LOF patients. IRT and antibiotic prophylaxis appear to decrease the frequency of infections and hospitalizations.

Entities:  

Keywords:  STAT3; autosomal dominant HIES; lung disease; primary immunodeficiency diseases; pulmonary surgical procedure

Mesh:

Substances:

Year:  2021        PMID: 33734873      PMCID: PMC8082030          DOI: 10.1089/ped.2020.1225

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol Pulmonol        ISSN: 2151-321X            Impact factor:   1.349


  25 in total

1.  The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long-term follow-up and genetic analysis.

Authors:  Mahmood Tavassoli; Hassan Abolhassani; Reza Yazdani; Mohsen Ghadami; Gholamreza Azizi; Sina Abdolrahim Poor Heravi; Tannaz Moeini Shad; Mostafa Kokabee; Masoud Movahedi; Hormoz Abdshahzadeh; Mohammad Gharagozlou; Nima Rezaei; Hossein Esmaeilzadeh; Soheila Aleyasin; Asghar Aghamohammadi
Journal:  Pediatr Allergy Immunol       Date:  2019-05-15       Impact factor: 6.377

Review 2.  Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.

Authors:  Jing Wu; Ji Chen; Zhi-Qing Tian; Hao Zhang; Ruo-Lan Gong; Tong-Xin Chen; Li Hong
Journal:  J Clin Immunol       Date:  2017-02-14       Impact factor: 8.317

3.  Gastrointestinal Manifestations of STAT3-Deficient Hyper-IgE Syndrome.

Authors:  Manish Arora; Preet Bagi; Anna Strongin; Jennifer Heimall; Xiongce Zhao; Monica G Lawrence; Apurva Trivedi; Carolyn Henderson; Amy Hsu; Martha Quezado; David E Kleiner; Aradhana M Venkatesan; Steven M Holland; Alexandra F Freeman; Theo Heller
Journal:  J Clin Immunol       Date:  2017-08-13       Impact factor: 8.317

Review 4.  Autosomal dominant hyper-IgE syndrome: When hematopoietic stem cell transplantation should be considered?

Authors:  Christina Oikonomopoulou; Evgenios Goussetis
Journal:  Pediatr Transplant       Date:  2020-06-04

Review 5.  Hyper IgE syndromes: clinical and molecular characteristics.

Authors:  Taha Al-Shaikhly; Hans D Ochs
Journal:  Immunol Cell Biol       Date:  2018-11-19       Impact factor: 5.126

6.  Diagnostic Delay of Primary Immunodeficiencies at a Tertiary Care Hospital in Peru- Brief Report.

Authors:  Liz E Veramendi-Espinoza; Jessica H Zafra-Tanaka; Gabriela A Pérez-Casquino; Wilmer O Córdova-Calderón
Journal:  J Clin Immunol       Date:  2017-05-08       Impact factor: 8.317

7.  Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder.

Authors:  B Grimbacher; S M Holland; J I Gallin; F Greenberg; S C Hill; H L Malech; J A Miller; A C O'Connell; J M Puck
Journal:  N Engl J Med       Date:  1999-03-04       Impact factor: 91.245

8.  Autosomal Dominant Hyper-IgE Syndrome in the USIDNET Registry.

Authors:  Yael Gernez; Alexandra F Freeman; Steven M Holland; Elizabeth Garabedian; Niraj C Patel; Jennifer M Puck; Kathleen E Sullivan; Javeed Akhter; Elizabeth Secord; Karin Chen; Rebecca Buckley; Elie Haddad; Hans D Ochs; Ramsay Fuleihan; John Routes; Mica Muskat; Patricia Lugar; Julien Mancini; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol Pract       Date:  2017-09-19

9.  [Genetic diagnosis of patients with primary agammaglobulinemia treated at third level peruvian centers].

Authors:  Edgar Matos-Benavides; David García-Gomero; Rosario Inocente-Malpartida; Wilmer Córdova-Calderón; Juan Aldave-Becerra
Journal:  Rev Peru Med Exp Salud Publica       Date:  2020-01-17

Review 10.  Signal Transducer and Activator of Transcription 3 Control of Human T and B Cell Responses.

Authors:  Elissa K Deenick; Simon J Pelham; Alisa Kane; Cindy S Ma
Journal:  Front Immunol       Date:  2018-02-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.